🇺🇸 FDA
Patent

US 7452887

Quinoline- and isoquinoline-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof

granted A61KA61K31/4709A61K31/4725

Quick answer

US patent 7452887 (Quinoline- and isoquinoline-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof) held by Amphora Discovery Corporation expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Amphora Discovery Corporation
Grant date
Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61K, A61K31/4709, A61K31/4725, A61K31/496, A61P